Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials

Patoulias, Dimitrios; Popovic, Djordje S; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi

Rezultati

eNauka > Rezultati > Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials

Naziv:	Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
Autori:	Patoulias, Dimitrios; Popovic, Djordje S ; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi
Godina:	2023
Publikacija:	JOURNAL OF DIABETES AND ITS COMPLICATIONS
ISSN:	1056-8727 Journal of Diabetes and Its Complications Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 37 br. 8 str. Art. No 108529
DOI:	10.1016/j.jdiacomp.2023.108529
WoS-ID:	001021247400001
Scopus-ID:	2-s2.0-85161264809
PMID:	37301063
URI:	https://enauka.gov.rs/handle/123456789/811152
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	23M23 - Rad u međ. časopisu

2
SCOPUS^TM

1
PubMed Central^TM

2
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.